{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:06:43Z","timestamp":1771038403760,"version":"3.50.1"},"reference-count":26,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Young children are particularly vulnerable to measles infections. Investigating the gap between the waning of maternal antibodies and onset of vaccination-induced immunity via seroprevalence studies can be hampered by recruiting enough young-aged participants. We present measles IgG-antibody results from 2148 patients aged 0 to 2 years, who were hospitalized with acute aseptic meningitis or encephalitis in Lower Saxony or Bremen. Measles serology was performed for differential diagnostics clarification of neurotropic pathogens, during syndromic surveillance between 2006 and 2024. At birth, 79% of children presented with measles IgG-antibodies, but only 30% of three-month-old patients and 11% of five-month-olds. From 0 to 10 months, seropositivity declined monthly by 8%. Over 95% of children aged six to 11 months were unprotected. From 11 months onwards, measles seroprevalence increased, reaching 80\u201390% towards the end of the second year of life. Our results indicate an absence of maternal measles IgG antibodies after nine months of age and that vaccination starts around 11 months of age; however, not all children had received vaccination by their second birthday. These findings confirm the current recommendation to advance first measles vaccination to nine months in high-exposure settings and support efforts to increase vaccination rates in small children and young adults.<\/jats:p>","DOI":"10.3390\/v17070973","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T15:19:31Z","timestamp":1752247171000},"page":"973","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Unprotected: Measles Seroprevalence in Children During the First Two Years of Life"],"prefix":"10.3390","volume":"17","author":[{"given":"Sophie","family":"Rettenbacher-Riefler","sequence":"first","affiliation":[{"name":"Department for Microbiology, Public Health Agency of Lower Saxony, 30449 Hanover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Holle","sequence":"additional","affiliation":[{"name":"Department for Infectious Disease Epidemiology and Surveillance, Public Health Agency of Lower Saxony, 30449 Hanover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mareike","family":"Wollenweber","sequence":"additional","affiliation":[{"name":"Department for Infectious Disease Epidemiology and Surveillance, Public Health Agency of Lower Saxony, 30449 Hanover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"ref_1","first-page":"3","article-title":"Aktuelles zu Masern in Deutschland und weltweit (Datenstand: 01.08.2022)","volume":"34","author":"Santibanez","year":"2022","journal-title":"Epid. Bull."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(21)02004-3","article-title":"Measles","volume":"399","author":"Dina","year":"2022","journal-title":"Lancet"},{"key":"ref_3","unstructured":"(2025, May 28). Survstat@RKI 2.0. Available online: https:\/\/survstat.rki.de\/."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7949","DOI":"10.1016\/j.vaccine.2011.08.081","article-title":"Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross-sectional study in children and adolescents (KiGGS)","volume":"29","author":"Mankertz","year":"2011","journal-title":"Vaccine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/infdis\/jir068","article-title":"Closer to the goal: Efforts in measles elimination in Germany","volume":"204","author":"Siedler","year":"2010","journal-title":"J. Inf. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/risa.12459","article-title":"The Costs and Valuation of Health Impacts of Measles and Rubella Risk Management Policies","volume":"36","author":"Thompson","year":"2016","journal-title":"Risk. Anal."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kreidl, P., Ammerer, D., W\u00fcrzner, R., Luckner Hornischer, A., von Laer, D., and Borena, W. (2019). Measles Elimination: Identifying Susceptible Sub-Populations to Tailor Immunization Strategies. Viruses, 11.","DOI":"10.3390\/v11080765"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1016\/j.vaccine.2007.06.020","article-title":"Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns","volume":"25","author":"Leuridan","year":"2007","journal-title":"Vaccine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jit143","article-title":"Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage","volume":"208","author":"Waaijenborg","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1586\/eri.10.126","article-title":"Early waning of maternal antibodies: Why immunization programs should be adapted over time","volume":"8","author":"Gagneur","year":"2010","journal-title":"Expert. Rev. Anti. Infect. Ther."},{"key":"ref_11","first-page":"203","article-title":"Impfempfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand: Juli 2001","volume":"28","author":"Impfkommission","year":"2001","journal-title":"Epid. Bull."},{"key":"ref_12","first-page":"3","article-title":"Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) beim Robert Koch-Institut-2020\/2021","volume":"35","author":"Impfkommission","year":"2020","journal-title":"Epid. Bull."},{"key":"ref_13","unstructured":"Wollenweber, M., Beyrer, K., Baillot, A., Monazahian, M., Holle, I., and Rettenbacher-Riefler, S. 20 years of MERIN (Meningitis and Encephalitis Registry in Lower Saxony and Bremen)\u2014Design and main results of a syndromic surveillance system. Eurosurveillance, 2025. submitted."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Luczynska, A., Beyrer, K., Holle, I., Baillot, A., Monazahian, M., Dreesmann, J., Mertens, E., and Rettenbacher-Riefler, S. (2024). Evaluation of 17 years of MERIN (Meningitis and Encephalitis register in Lower Saxony, Germany) surveillance system: Participants acceptability survey, completeness and timeliness of data. BMC Health Serv. Res., 24.","DOI":"10.1186\/s12913-023-10482-y"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s001030050004","article-title":"Einsch\u00e4tzung der Masernsituation in Deutschland","volume":"43","author":"Gerike","year":"2000","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2400684","DOI":"10.2807\/1560-7917.ES.2025.30.16.2400684","article-title":"Seroprevalence against measles, Austria, stratified by birth years 1922 to 2024","volume":"30","author":"Springer","year":"2025","journal-title":"Eurosurveillance"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Smetana, J., Chlibek, R., Hanovcova, I., Sosovickova, R., Smetanova, L., Gal, P., and Dite, P. (2017). Decreasing Seroprevalence of Measles Antibodies after Vaccination\u2014Possible Gap in Measles Protection in Adults in the Czech Republic. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0170257"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"100128","DOI":"10.1016\/j.lanepe.2021.100128","article-title":"Seroprevalence of Measles-, Mumps-, and Rubella-specific antibodies in the German adult population\u2014Cross-sectional analysis of the German Health Interview and Examination Survey for Adults (DEGS1)","volume":"7","author":"Friedrich","year":"2021","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Khampanisong, P., Pauly, M., Nouanthong, P., Vickers, M.A., Virachith, S., Xaydalasouk, K., Black, A.P., Muller, C.P., and H\u00fcbschen, J.M. (2021). Waning of Maternal Antibodies against Measles Suggests a Large Window of Susceptibility in Infants in Lao People\u2019s Democratic Republic. Pathogens, 10.","DOI":"10.3390\/pathogens10101316"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"c1626","DOI":"10.1136\/bmj.c1626","article-title":"Early waning of maternal measles antibodies in era of measles elimination: Longitudinal study","volume":"340","author":"Leuridan","year":"2010","journal-title":"BMJ"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.vaccine.2018.01.002","article-title":"Waning of measles maternal antibody in infants in measles elimination settings\u2014A systematic literature review","volume":"36","author":"Guerra","year":"2018","journal-title":"Vaccine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e20190630","DOI":"10.1542\/peds.2019-0630","article-title":"Measles antibody levels in young infants","volume":"144","author":"Science","year":"2019","journal-title":"Pediatrics"},{"key":"ref_23","first-page":"6","article-title":"Impfquoten von Kinderschutzimpfungen in Deutschland\u2014Aktuelle Ergebnisse aus der RKI-Impfsurveillance","volume":"49","author":"Rieck","year":"2021","journal-title":"Epid. Bull."},{"key":"ref_24","first-page":"1045","article-title":"Risk factors for delayed or missed measles vaccination in young children","volume":"52","author":"Grote","year":"2009","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00103-019-02901-5","article-title":"Durchimpfung von Kindern und Jugendlichen in Deutschland: Aktuelle Daten aus KiGGS Welle 2 und Trends aus der KiGGS-Studie","volume":"62","author":"Kuhnert","year":"2019","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"ref_26","first-page":"3","article-title":"Gesetz f\u00fcr den Schutz vor Masern und zur St\u00e4rkung der Impfpr\u00e4vention (Masernschutzgesetz)","volume":"10","author":"Siedler","year":"2020","journal-title":"Epid. Bull."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/7\/973\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:08:22Z","timestamp":1760033302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/7\/973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["v17070973"],"URL":"https:\/\/doi.org\/10.3390\/v17070973","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}